Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (361-370 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis and Haemostasis|January 1, 1994
Prevalence and induction of circulating antibodies against recombinant staphylokinaseP J Declerck, S Vanderschueren, J Billiet, et al.
Journal of Internal Medicine|October 1, 1994
Development of novel thrombolytic agentsD Collen, D P De Bono, H R Lijnen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosisD Collen, J M Stassen, M Blaber, et al.
The Journal of Biological Chemistry|August 26, 1998
NH2-terminal structural motifs in staphylokinase required for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.
The Journal of Biological Chemistry|July 3, 1999
Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 geneH Ding, A M Benotmane, G Suske, et al.
Thrombosis and Haemostasis|December 1, 1996
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.
Thrombosis and Haemostasis|July 10, 1998
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.
The Journal of Clinical Investigation|March 1, 1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosisC Korninger, O Matsuo, R Suy, et al.
Pageof 72

Showing results (361-370 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis and Haemostasis|January 1, 1994
Prevalence and induction of circulating antibodies against recombinant staphylokinaseP J Declerck, S Vanderschueren, J Billiet, et al.
Journal of Internal Medicine|October 1, 1994
Development of novel thrombolytic agentsD Collen, D P De Bono, H R Lijnen, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosisD Collen, J M Stassen, M Blaber, et al.
The Journal of Biological Chemistry|August 26, 1998
NH2-terminal structural motifs in staphylokinase required for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.
The Journal of Biological Chemistry|July 3, 1999
Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 geneH Ding, A M Benotmane, G Suske, et al.
Thrombosis and Haemostasis|December 1, 1996
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.
Thrombosis and Haemostasis|July 10, 1998
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.
The Journal of Clinical Investigation|March 1, 1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosisC Korninger, O Matsuo, R Suy, et al.
Pageof 72